Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial “HYPO-RT-PC”

2016 ◽  
Vol 96 (5) ◽  
pp. 938-939 ◽  
Author(s):  
A. Widmark ◽  
A. Gunnlaugsson ◽  
L. Beckman ◽  
C. Thellenberg-Karlsson ◽  
M. Hoyer ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Iii ◽  
Intermediate Risk ◽  
Phase Iii Trial ◽  
Fractionated Radiotherapy ◽  
Risk Prostate Cancer ◽  
Early Toxicity ◽  
Conventionally Fractionated

A phase III trial of short-term androgen deprivation therapy in intermediate-risk prostate cancer treated with radiotherapy.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 5019-5019 ◽  
Author(s):  
Abdenour Nabid ◽  
Nathalie Carrier ◽  
Eric Vigneault ◽  
Luis Souhami ◽  
Céline Lemaire ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Deprivation Therapy ◽  
Androgen Deprivation ◽  
Phase Iii ◽  
Intermediate Risk ◽  
Short Term ◽  
Phase Iii Trial ◽  
Risk Prostate Cancer

Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial

2021 ◽  
Vol 143 ◽  
pp. 64-74
Author(s):  
Abdenour Nabid ◽  
Nathalie Carrier ◽  
Eric Vigneault ◽  
Thu Van Nguyen ◽  
Peter Vavassis ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Deprivation Therapy ◽  
Androgen Deprivation ◽  
Phase Iii ◽  
Intermediate Risk ◽  
Phase Iii Trial ◽  
Risk Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document